Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strepsils Max Plus for Postoperative Sore Throat
NCT03944655Completed
- Start
- Jan 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Strepsils Max Plus in postoperative sore throat (POST) (2 arms). Primary endpoint: Incidence of postoperative sore throat at 24 hours. Started Jan 2019; status: completed.
02
Drugs
Strepsils Max Plus
03
Conditions
postoperative sore throat (POST)
Beyond the preview
Go deeper on NCT03944655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03944655.